Insider Stock Trading History of Fisherman Jason S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Fisherman Jason S since year 2005. The trader's CIK number is 1197540. At the time of this reporting, Fisherman Jason S is the Director of Achillion Pharmaceuticals Inc . (stock ticker symbol ACHN). See this page for all insider trading activities at Achillion Pharmaceuticals Inc .

Note that in the past FISHERMAN JASON S also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Fisherman Jason S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-12-22 ACHN Achillion Pharmaceuticals Inc Buy 10,000 3.96 39,600
2013-11-19 ACHN Achillion Pharmaceuticals Inc Buy 5,000 2.56 12,800
2013-11-18 ACHN Achillion Pharmaceuticals Inc Buy 10,000 2.67 26,700
2013-08-14 ACHN Achillion Pharmaceuticals Inc Buy 5,000 6.83 34,150
2013-06-21 ACHN Achillion Pharmaceuticals Inc Buy 10,000 7.63 76,300
2013-06-03 ACHN Achillion Pharmaceuticals Inc Buy 10,000 7.87 78,700
2011-07-21 ACHN Achillion Pharmaceuticals Inc Sale 125 7.96 995
2011-07-18 ACHN Achillion Pharmaceuticals Inc Sale 85 7.48 635
2011-07-19 ACHN Achillion Pharmaceuticals Inc Sale 59 7.48 441
2011-07-20 ACHN Achillion Pharmaceuticals Inc Sale 39 7.46 291
2011-07-13 ACHN Achillion Pharmaceuticals Inc Sale 200 7.80 1,560
2011-07-14 ACHN Achillion Pharmaceuticals Inc Sale 140 7.83 1,095
2011-07-15 ACHN Achillion Pharmaceuticals Inc Sale 117 7.47 874
2011-07-11 ACHN Achillion Pharmaceuticals Inc Sale 24 7.81 187
2011-07-12 ACHN Achillion Pharmaceuticals Inc Sale 249 7.86 1,958
2011-07-08 ACHN Achillion Pharmaceuticals Inc Sale 77 8.01 616
2010-10-27 AEGR Aegerion Pharmaceuticals, Inc. Buy 739 9.50 7,020
2005-09-08 EXEL Exelixis Inc Sale 986 7.87 7,756
2005-09-08 EXEL Exelixis Inc Sale 986 7.87 7,756

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fisherman Jason S (Director of Achillion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.